APA (7th ed.) Citation

Ruderman, E. M. (2012). Overview of safety of non-biologic and biologic DMARDs. Rheumatology (Oxford, England), 51(suppl 6), vi37-vi43. https://doi.org/10.1093/rheumatology/kes283

Chicago Style (17th ed.) Citation

Ruderman, E. M. "Overview of Safety of Non-biologic and Biologic DMARDs." Rheumatology (Oxford, England) 51, no. suppl 6 (2012): vi37-vi43. https://doi.org/10.1093/rheumatology/kes283.

MLA (9th ed.) Citation

Ruderman, E. M. "Overview of Safety of Non-biologic and Biologic DMARDs." Rheumatology (Oxford, England), vol. 51, no. suppl 6, 2012, pp. vi37-vi43, https://doi.org/10.1093/rheumatology/kes283.